Moderate dose of hydroxyurea in children with sickle cell disease and stroke. Preliminary results

Twenty children with sickle cell anemia, two with SC hemoglobinopathy and one with S/â0 thalassemia were treated, with a previous stroke or abnormal ultrasound transcranial Doppler (TCD) flow velocities more than 170 cm/s. The mean follow-up was of 41 ± 19 months. Hydroxyurea (HU) at a dose of 25 mg...

Full description

Bibliographic Details
Main Authors: Sergio Machín-García, Andrea Menéndez-Veitía, Claudio Scherle-Matamoros, Eva Svarch, Alejandro González-Otero, Alberto Arencibia-Núñez, Adys Gutiérrez-Díaz, Rosa M Lam-Díaz
Format: Article
Language:Spanish
Published: Editorial Ciencias Médicas
Series:Revista Cubana de Hematología, Inmunología y Hemoterapia
Subjects:
Online Access:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892014000100004&lng=en&tlng=en